NLRP3 and Alzheimer disease: Despite the extensive evidence, these results have been recently challenged by Srinivasan et al., as conditional or global Nlrp3 and Caspase-1 knockout failed to rescue AD pathology in AppNL-G-F and APP/PS1 mice [175].